Type III and type VI collagen neoepitopes are associated with disease severity in systemic sclerosis

By afschroeder • November 16, 2025

Ayla AY, Bernstein EJ, Zhang M, VanBuren JM, Castelino FV, Chung L, Evnin L, Frech TM, Gordon JK, Hant FN, Hummers LK, Khanna D, Lakin KS, Lebiedz-Odrobina D, Luo Y, Makol A, Mayes M, McMahan ZH, Molitor JA, Moore DF, Richardson C, Sandorfi N, Shah AA, Shah A, Shanmugam VK, Skaug B, Steen VD, Volkmann ER, Zahn C, Zheng WJ, Assassi S. Type III and type VI collagen neoepitopes are associated with disease severity in systemic sclerosis. J Rheumatol. 2025 Nov 15:jrheum.2025-0532. doi: 10.3899/jrheum.2025-0532. Epub ahead of print. PMID: 41241390.

Tags: Publications, Rheumatology

JPEN Journal Club 97. Splitting studies

Koretz RL. JPEN Journal Club 97. Splitting studies. JPEN J Parenter Enteral Nutr. 2025 Nov 16. doi: 10.1002/jpen.70035. Epub ahead of print. PMID: 41241824.

Evaluating oral selexipag in PAH: Insights on survival, safety and dosing patterns from the complete observation period of GRIPHON and its open-label extension

McLaughlin VV, Howard L, Elwing J, Fernandes CC, Gaine S, Galiè N, Oudiz RJ, Stefani M, Stickel S, Strachan P, Tamura Y, Kim NH. Evaluating[...]

Dose-escalated stereotactic body radiotherapy re-irradiation in patients with recurrent head and neck cancer: a prospective phase 2 study using automated non-coplanar volumetric modulated arc therapy

Nikitas J, Ma TM, Cook K, Woods K, Kishan AU, Reddy VK, Hegde JV, John MS, Chai-Ho W, Wong D, Chu FI, Felix C, Tenn[...]